Abstract
Among humanized monoclonal antibodies, bevacizumab specifically binds to vascular endothelial growth factor A (VEGF-A). VEGF-A is an overexpressed biomarker in cervix carcinoma and is involved in the development and maintenance of tumor-associated neo-angiogenesis. The non-invasive positron emission tomography using radiolabeled target-specific antibodies (immuno-PET) provides the longitudinal and quantitative assessment of tumor target expression. Due to antibodies having a long-circulating time, radioactive metal ions (e.g., 52Mn) with longer half-lives are the best candidates for isotope conjugation. The aim of our preclinical study was to assess the biodistribution and tumor-targeting potential of 52Mn-labeled DOTAGA-bevacizumab. The VEGF-A targeting potential of the new immuno-PET ligand was assessed by using the VEGF-A expressing KB-3-1 (human cervix carcinoma) tumor-bearing CB17 SCID mouse model and in vivo PET/MRI imaging. Due to the high and specific accumulation found in the subcutaneously located experimental cervix carcinoma tumors, [52Mn]Mn-DOTAGA-bevacizumab is a promising PET probe for the detection of VEGF-A positive gynecological tumors, for patient selection, and monitoring the efficacy of therapies targeting angiogenesis.
Funder
National Academy of Scientist Education Program of the National Biomedical Foundation
European Union
European Social Fund and National Research, Development, and Innovation Office
Thematic Excellence Programme
KDP-2021 program of the Ministry for Innovation and Technology
Reference39 articles.
1. A Review of Cervical Cancer: Incidence and Disparities;Buskwofie;J. Natl. Med. Assoc.,2020
2. Cervical Cancer Survival Rates (2022, November 21). Cancer 5 Year Survival Rates. Available online: https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/survival.html.
3. Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis;Arbyn;Lancet Glob. Health,2019
4. Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities;Lugano;Cell. Mol. Life Sci.,2019
5. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies;Shibuya;Genes Cancer,2011
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献